Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups

Graham McClorey

PhD, BSc (Hons)

Postdoctoral Research Scientist

I completed my PhD program at the University of Western Australia focusing on the development of antisense oligonucleotides to modulate splicing in disease models of Duchenne muscular dystrophy, in particular in canine and human cellular models.

I have been a Postdoctoral Research Scientist in the field of pre-clinical translational research for the past 11 years where my focus has been predominantly on development of antisense oligonucleotide therapeutics for neuromuscular diseases, in particular for Duchenne muscular dystrophy (DMD). In my current role, I am lead scientist and Project Manager in the group for a number of collaborative programs with pharmaceutical partners including Pfizer and Wave LifeSciences, focusing on pre-clinical development of novel therapeutic drugs for DMD.